Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer

Oral antineoplastic agent that induces apoptosis in cancerous cells.

Hormonal therapy to suppress testosterone as a standard treatment for Prostate Cancer.

Hormonal therapy used as lead in treatment with luteinizing hormone-releasing hormone (LHRH) agonist to prevent the initial rise in testosterone (testosterone flare) seen during the first dose of LHRH agonists.